Document: Agenda - PDCO agenda of the 14-17 October 2025 meeting-2025/10/14

Document: Timetable: Type II variation and worksharing application monthly assessment-2025/10/14

Document: Timetable: Type II variation and worksharing application alternative monthly assessment-2025/10/14

Document: Timetable: Post-authorisation measure (PAM) assessed by PRAC-2025/10/14

Document: Respiporc Flu3 : EPAR - Medicine overview-2025/10/14

Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment-2025/10/14

Document: Respiporc Flu3 : EPAR - All Authorised presentations-2025/10/14

Document: Respiporc Flu3 : EPAR - Scientific Discussion-2025/10/14

Document: Suvaxyn Circo+MH RTU : EPAR - Public assessment report-2025/10/14

Document: Annex to agenda of the CHMP meeting 13-16 October 2025-2025/10/13